THANC Foundation logo 1

Our site uses cookies and we've updated our privacy policy.

Got it
Diagnostics November 29th, 2018

Trimodality Management of Sinonasal Undifferentiated Carcinoma

Sinonasal undifferentiated carcinoma (SNUC) represents a particularly rare subtype of sinonasal cancer that is highly aggressive. There remain several areas of uncertainty in the management of this disease, including sequencing of the various therapeutic modalities, optimal chemotherapy agents and dosing, and optimal radiation dosing and targets. In this present study, THANC aims to report the outcomes of different treatment modalities of SNUC and highlight the impact of a trimodality approach on the outcomes of this disease.

Waleed F. Mourad; David Hauerstock; Rania A. Shourbaji; Kenneth S. Hu; Bruce Culliney; Zujun Li; Adam Jacobson; Theresa Tran; Spiros Manolidis; Stimson Schantz; Mark Urken; Mark Persky; Louis B. Harrison

Published by

American Journal of Clinical Oncology, December 2013

   Read the Abstract

Apply for the Research Associate Program

Required Documents

Each file should be no more than 2mb in size. Only PDFs accepted.